Altimmune (ALT) Net Income - Minority (2016 - 2017)
Altimmune (ALT) reported Net Income - Minority of -$9.3 million for Q4 2017, down 154776.81% year-over-year from N/an in Q4 2016, and down 154776.81% quarter-over-quarter from -$5993.0 in Q4 2016.
Altimmune (ALT) Net Income - Minority (2016 - 2017) Analysis & Trends
Altimmune (ALT) has 2 years of Net Income - Minority data on file, last reported at -$9.3 million in Q4 2017.
- Net Income - Minority for Q4 2017 came in at -$9.3 million, down 154776.81% year-over-year; the trailing twelve-month figure through Dec 2017 was -$9.3 million (down 154776.81% YoY), and the FY2017 annual result was -$9.3 million, down 154776.81% from the prior year.
- Net Income - Minority eased to -$9.3 million in Q4 2017 per ALT's latest filing, from -$5993.0 in the prior quarter.
- Over five years, Net Income - Minority peaked at -$5993.0 in Q4 2016 and troughed at -$9.3 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income - Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -9.28 Mn |
| Dec 31, 2016 | -5,993.00 |